Cusabio
ELISA Kit
Rat matrix metalloproteinase 9/Gelatinase B , MMP-9 ELISA Kit
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq]
Product Name:

Rat matrix metalloproteinase 9/Gelatinase B , MMP-9 ELISA Kit

Product Type:
ELISA Kit
Code:
CSB-E08008r
Alias:
CLG4B, GELB, MANDP2, MMP-9, macrophage gelatinase|matrix metalloproteinase 9|matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)|type V collagenase
Size:
96T
Species:
Rat
other species: Bovine Dog Mouse Rabbit Sheep Guinea pig Pig Hamster Human
Target Name:
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
Abbreviation:
MMP9
Protein Biological Process 1:
Developmental Protein
Protein Biological Process 3:
Collagen degradation
Detect Range:
15.6 pg/ml-1000 pg/ml
Sensitivity:
3.9 pg/ml
Assay Time:
1-5h
Sample Volume:
50-100ul
Detection wavelengt:
450 nm
Download:

Protocol may be improved. Please feel free to contact CUSABIO product specialist to obtain the latest version.

Specificty: This assay has high sensitivity and excellent specificity for detection of Rat MMP9. No significant cross-reactivity or interference between Rat MMP9 and analogues was observed.
Precision: Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Sample collection and storage: Serum: Use a serum separator tube (SST) and allow samples to clot for two hours at room temperature or overnight at 4°C before centrifugation for 15 minutes at 1000 ×g. Remove serum and assay immediately or aliquot and store samples at -20°C or -80°C. Avoid repeated freeze-thaw cycles.
Plasma: Collect plasma using EDTA, or heparin as an anticoagulant. Centrifuge for 15 minutes at 1000 ×g at 2-8°C within 30 minutes of collection. Assay immediately or aliquot and store samples at -20°C or -80°C. Avoid repeated freeze-thaw cycles.
Assay procedure: Bring all reagents and samples to room temperature before use. Centrifuge the sample again after thawing before the assay. It is recommended that all samples and standards be assayed in duplicate.
1. Prepare all reagents, working standards, and samples as directed in the previous sections.
2. Refer to the Assay Layout Sheet to determine the number of wells to be used and put any remaining wells and the desiccant back into the pouch and seal the ziploc, store unused wells at 4°C.
3. Add 100μl of standard and sample per well. Cover with the adhesive strip provided. Incubate for 2 hours at 37°C. A plate layout is provided to record standards and samples assayed.
4. Remove the liquid of each well, don't wash.
5. Add 100μl of Biotin-antibody (1x) to each well. Cover with a new adhesive strip. Incubate for 1 hour at 37°C. (Biotin-antibody (1x) may appear cloudy. Warm up to room temperature and mix gently until solution appears uniform.)
6. Aspirate each well and wash, repeating the process two times for a total of three washes. Wash by filling each well with Wash Buffer (200μl) using a squirt bottle, multi-channel pipette, manifold dispenser, or autowasher, and let it stand for 2 minutes, complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining wash Buffer by aspirating ordecanting. Invert the plate and blot it against clean paper towels.
7. Add 100μl of HRP-avidin (1x) to each well. Cover the microtiter plate with a new adhesive strip. Incubate for 1 hour at 37°C.
8. Repeat the aspiration/wash process for five times as in step 6.
9. Add 90μl of TMB Substrate to each well. Incubate for 15-30 minutes at 37°C. Protect from light.
10. Add 50μl of Stop Solution to each well, gently tap the plate to ensure thorough mixing.
11. Determine the optical density of each well within 5 minutes, using a microplate reader set to 450 nm. If wavelength correction is available, set to 540 nm or 570 nm. Subtract readings at 540 nm or 570 nm from the readings at 450 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 450 nm without correction may be higher and less accurate.
Calculation of results: Using the professional soft "Curve Expert 1.3" to make a standard curve is recommended, which can be downloaded from our web.
Average the duplicate readings for each standard and sample and subtract the average zero standard optical density.
Create a standard curve by reducing the data using computer software capable of generating a four parameter logistic (4-PL) curve-fit. As an alternative, construct a standard curve by plotting the mean absorbance for each standard on the x-axis against the concentration on the y-axis and draw a best fit curve through the points on the graph. The data may be linearized by plotting the log of the MMP9 concentrations versus the log of the O.D. and the best fit line can be determined by regression analysis. This procedure will produce an adequate but less precise fit of the data.
If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor.

Literature1Literature2Literature3Literature4Literature5Literature6Literature7

TitleInduction of pulmonary fibrosis by cerium oxide nanoparticles
Linkhttp://www.sciencedirect.com/science/article/pii/S0041008X12002037
Type of publicationProduct-specific
Impact Factor4.447
JournalToxicology and Applied Pharmacology
TitleTherapeutic time window of hypothermia is broader than cerebral artery flushing in carotid saline infusion after transient focal ischemic stroke in rats
Linkhttp://www.ingentaconnect.com/content/maney/nres/2012/00000034/00000007/art00005
Type of publicationProduct-specific
Impact Factor1.522
JournalNeurological Research,
TitleEndothelin
Linkhttp://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2010.06680.x/full
Type of publicationProduct-specific
Impact Factor4.061
JournalJournal of Neurochemistry
TitleInterrupted intracarotid artery cold saline infusion as an alternative method for neuroprotection after ischemic stroke
Linkhttp://thejns.org/doi/abs/10.3171/2012.5.FOCUS1215
Type of publicationProduct-specific
Impact Factor2.867
JournalNeurosurgical Focus
TitleThe wound healing effects of vitamin A eye drops after a corneal alkali burn in rats
AuthorKim EC et al
PMID23106861
Linkhttp://www.ncbi.nlm.nih.gov/pubmed/?term=23106861
Type of publicationProduct-specific
Year2012
Impact Factor2.629
JournalActa Ophthalmol
Other information 2012 Nov;90(7):e540-6. doi: 10.1111/j.1755-3768.2012.02496.x.
TitleBevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in rats
AuthorKim EC et al
PMID23433183
Linkhttp://www.ncbi.nlm.nih.gov/pubmed/?term=23433183
Type of publicationProduct-specific
Year2013
Impact Factor1.977
JournalClin Experiment Ophthalmol
Other information2013 Feb 21. doi: 10.1111/ceo.12085. [Epub ahead of print]
TitleThe Effect of Erythropoietin on Anastomotic Healing of Irradiated Rats
Linkhttp://informahealthcare.com/doi/abs/10.3109/08941939.2011.611583
Type of publicationProduct-specific
JournalInforma Healthcare